Ex Vivo Lung Perfusion and Allograft Failure After Lung Transplantation: A National Target Trial Emulation
OBJECTIVE: Ex vivo lung perfusion (EVLP) has been championed as a disruptive strategy to expand the lung transplantation (LT) donor pool, yet contemporary evidence remains limited. Using a real-world cohort, we emulated a randomized controlled trial (RCT) to characterize the causal effect of EVLP on post-LT survival. METHODS: LT recipients ≥18 years were identified from the 2018-2025 Organ Procurement and Transplantation Network. Annual hospital LT volume was computed; centers in the top quartile (>54 LT/y) were designated high-volume centers (HVCs). Using target trial emulation with clone-censor-weight methodology, we simulated a pragmatic, open-label RCT comparing EVLP with standard allografts at HVCs and non-HVCs. Survival was evaluated using Kaplan-Meier and multivariable Cox models. RESULTS: Among 20,627 LTs, 1419 (7%) received EVLP allografts. The proportion of EVLP allografts increased across all centers, from 5% in 2018 to 10% in 2024 and 8% in 2025 (P trend <0.001). In the Lung Allocation Score era, LT using EVLP allografts yielded similar 2-year outcomes at HVC, but inferior outcomes at non-HVC. In the Composite Allocation Score period, however, EVLP was associated with significantly worse survival at non-HVC. In the emulated RCT among CAS-era recipients, EVLP remained independently associated with similar outcomes at HVC, but increased 2-year hazards of patient mortality (HR: 2.43, CI: 1.36-4.34, P=0.003) and allograft failure at non-HVC (HR: 2.52, CI: 1.31-4.84, P=0.005). CONCLUSIONS: EVLP was associated with comparable survival at HVC but inferior outcomes at non-HVC. These findings highlight the critical role of hospital context and center experience in determining the effectiveness and safety of EVLP and call for standardization of protocols across centers.
Authors
- Richard Jay Shemin
- Peyman Benharash (ORCID: https://orcid.org/0000-0002-4705-0262)
- Deep Mehta (ORCID: https://orcid.org/0000-0003-4578-3400)
- Yas Sanaiha (ORCID: https://orcid.org/0000-0002-3976-5620)
- Syed Shahyan Bakhtiyar
- Sara Sakowitz (ORCID: https://orcid.org/0009-0004-7318-7571)
Institutions
- University of California, Los Angeles (US)
- University of Utah (US)
- University of California System (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/sla.0000000000007203
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00